Business insights and opinions from the Editors of Hoover's
ER docs and vampires take note: Scientists have figured out how to turn embryonic stem cells into human blood.
In a study published in the (aptly named) journal Blood last week, researchers at a company called Advanced Cell Technology tell how exposing …
While the big for-profit hospital operators continue their long-term turnarounds (HMA, Tenet, and LifePoint have all posted financial improvements this quarter) and politicians of all stripes debate the merits of expanded health insurance coverage, the nation’s health …
The world of monoclonal antibodies and genetic testing may seem far removed from the realm of mortgage-backed securities and the other bogeymen of the current credit crisis, but the biotech industry is still feeling the fear. Despite an increasing number of profitable biotech companies, like …
Counting itself one of the luckiest girls in town this week, APP Pharmaceuticals got a $3.7 billion engagement ring from Fresenius SE, the German health care group best known for its worldwide network of dialysis clinics.
Fresenius is acquiring …
Competition among developers of diabetes drugs heated up this week, as news related to a class of therapies called incretin mimetics put pressure on Amylin Pharmaceutical’s Byetta, the first such drug to win regulatory approval. Amylin co-markets the drug with …
Are too few cancer drugs winning approval from the FDA? That’s the question Richard Pazdur, head of the agency’s oncology division, gets asked in an interview with BusinessWeek’s Catherine Arnst (via GoozNews).
Pazdur has been in charge of cancer drug approvals in …
Layoffs in the pharmaceutical sector continue apace, with Merck announcing it will cut its US sales force by about 15% in order to curb the hurt from falling Vytorin sales and the FDA’s rejection of its Cordaptive cholesterol drug. Merck’s reps aren’t the …
A front-page article in the Wall Street Journal yesterday highlights the common practice among US hospitals of requiring up-front payments from uninsured or under-insured patients before they’ll provide treatment.
The story describes the plight of Lisa Kelly, a Lousiana woman diagnosed with leukemia and …
